Lactose NZ wins major GSK contract
Fonterra subsidiary Lactose New Zealand will supply GlaxoSmithKline with half its global requirement for inhalation-grade lactose from a newly opened plant, reports Phil Taylor.
Fonterra subsidiary Lactose New Zealand will supply GlaxoSmithKline with half its global requirement for inhalation-grade lactose from a newly opened plant, reports Phil Taylor.
A study showing that drugs distributed in blister packages rather than in bottles increase the likelihood that medications will be taken properly, could help encourage the take-up of unit-dose packaging in the US market, reports Phil Taylor.
A former editor of the British Medical Journal (BMJ) claims that medical journals are an extension of the marketing arm of pharmaceutical companies, placing editors in difficult positions as company-funded trials are becoming increasingly popular.
Magellan Biosciences has acquired TekCel, a tool provider for life science research, in a move that adds automated sample-management to its advanced technology portfolio for life science customers.
Packaging giant Alcan has reached an agreement to purchase Interglass, a privately owned company that makes glass vials and ampoules, in a move that expands Alcan Packaging's position in the North American pharmaceutical packaging market.